Since the challenge issued by the 2013 London summit, many nations have substantially increased funding for dementia. Yet to reach the ambitious goals to develop a disease-modifying therapy, improve care and increase awareness by 2025, governments must ask afresh how it can further support science and civil society on this journey.

  • Matt Hancock MP

    Secretary of State for Health and Social Care

    United Kingdom

  • Hugo de Jonge

    Deputy Prime Minister and Minister of Health, Welfare and Sport

    The Netherlands

  • Kenji Suwazono

    Assistant Minister for Health and Welfare


  • Ulrik Vestergaard Knudsen

    Deputy Secretary General

    Organisation for Economic Co-operation and Development (OECD)